Form 4 for RVMD Revolution Medicines, Inc.
Accepted 2024-12-18 00:00:00 ET · period of report 2024-12-16 · accession 0001610717-24-000543 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2024-12-18 | 2024-12-16 | RVMD | Anders Jack | CFO | S - Sale | $45.40 | -2,635 | 96.5K | -3% | -$119.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-16 | S | D | 2,635 | $45.40 | 96,470 | D | — | — | (F2) Includes 173 shares acquired under the Issuer's Employee Stock Purchase Plan on November 30, 2024. (F3) Includes 44,876 RSUs. |